Research Topics
Species | Xavier F BoschSummaryCountry: Spain Publications
| Collaborators
|
Detail Information
Publications
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16Itzel E Calleja-Macias
Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697-3900, USA
J Virol 79:13630-40. 2005..Some had one, two, or three amino acid substitutions in these regions, which might indicate biological and pathogenic diversity between the variants of each HPV type...
Human Papillomavirus type distribution in invasive cervical cancer in UgandaMichael Odida
Department of Pathology, Faculty of Medicine, Makerere University, Kampala, Uganda
BMC Infect Dis 8:85. 2008..We conducted a study aiming to describe Human Papillomavirus (HPV) type distribution in invasive cervical carcinoma in Uganda...
The causal relation between human papillomavirus and cervical cancerF X Bosch
Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, Gran Via Km 2 7 s n 08907 L Hospitalet de Llobregat, 08907 Barcelona, Spain
J Clin Pathol 55:244-65. 2002..It is the right time for medical societies and public health regulators to consider this evidence and to define its preventive and clinical implications. A comprehensive review of key studies and results is presented...
The epidemiology of human papillomavirus infection and cervical cancerF Xavier Bosch
Institut Catala d Oncologia, Epidemiology and Cancer Registration Unit, E 08907 L Hospitalet de Llobregat, Barcelona, Spain
Dis Markers 23:213-27. 2007..Women exposed to the Human Immunodeficiency Virus (HIV) are at high risk for HPV infection, HPV DNA persistency and progression of HPV lesions to cervical cancer...
Prevention strategies of cervical cancer in the HPV vaccine eraXavier Bosch
, Epidemiology and Cancer Registration Unit, Avda. Gran Via s/n Km. 2, 708907 L'Hospitalet de Llobregat, Barcelona, Spain
Gynecol Oncol 103:21-4. 2006
Epidemiology of hepatocellular carcinomaF Xavier Bosch
Epidemiology and Cancer Registration Unit, IDIBELL, Institut Catala d Oncologia, Avda Gran Via s n, Km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
Clin Liver Dis 9:191-211, v. 2005..Primary liver cancer is the first human cancer largely amenable to prevention using hepatitis B virus vaccines and screening of blood and blood products for hepatitis B and C viruses...
Primary liver cancer: worldwide incidence and trendsF Xavier Bosch
Epidemiology and Cancer Registration Unit, IDIBELL Institut Català d Oncologia, Avda Gran Via s n, Km 2 7 08907 L Hospitalet de Llobregat, Barcelona, Spain
Gastroenterology 127:S5-S16. 2004..Primary liver cancer is the first human cancer largely amenable to prevention using hepatitis B virus vaccines and screening of blood and blood products for hepatitis B and C viruses...
Human papillomavirus in cervical cancerF Xavier Bosch
Servei dEpidemiologia i Registre del Càncer, Institut Català dOncologia, Av Gran Via, s n km 2 7, 08907 LHospitalet de Llobregat, Barcelona, Spain
Curr Oncol Rep 4:175-83. 2002....
Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conferenceF X Bosch
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
J Clin Pathol 54:163-75. 2001..This leader summarises the highlights presented at the conference (the full text of the abstracts and lectures can be found at www.hpv2000.com). Relevant material in Spanish can be found at www.aepcc.org...
Epidemiology of human papillomavirus infections: new options for cervical cancer preventionF Xavier Bosch
Epidemiology and Cancer Registration Unit SERC, Catalan Institute of Oncology ICO, Hospital Duran i Reynals, Avenida Gran Via, s n km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
Salud Publica Mex 45:S326-39. 2003..Time is ripe for exploring in depth the clinical implications of current achievements and to devise novel strategies for the prevention of cervical cancer. This paper is available too at: http://www.insp.mx/salud/index.html...
The viral etiology of cervical cancerF Xavier Bosch
Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, Hospital Duran i Reynals, Gran Via km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
Virus Res 89:183-90. 2002..This is a subjective evaluation that could be guided by a careful description of the most relevant studies and findings...
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studySilvia de Sanjose
IDIBELL, Institut Català d Oncologia Catalan Institute of Oncology, L Hospitalet de Llobregat, Barcelona, Spain
Lancet Oncol 11:1048-56. 2010..We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical cancer...
[Human papillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners]S de Sanjose
Servicio de Epidemiología y Registro del Cáncer, Institut Catala d Oncologia, Barcelona
Med Clin (Barc) 115:81-4. 2000..The study was designed to estimate the prevalence of HPV infection and the related risk of cervical cancer among imprisoned women...
The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in EuropeJosepa Ribes
Catalan Cancer Plan, IDIBELL, Catalan Institute of Oncology, Avda Gran Via s n, Km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
J Hepatol 49:233-42. 2008..To assess the variability of liver cancer (LC) risk associated with hepatitis B (HBV) and hepatitis C (HCV) viruses and alcohol intake in 2002 throughout Europe...
Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countriesK S Louie
Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Hospitalet del Llobregat Barcelona, Barcelona, Spain
Br J Cancer 100:1191-7. 2009..These data confirm AFSI and AFB as risk factors for ICC in eight developing countries, but any independent effects of these two events could not be distinguished...
Epidemiology of liver cancer in EuropeF X Bosch
L Hospitalet de Llobregat, Barcelona, Spain
Can J Gastroenterol 14:621-30. 2000....
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisSilvia de Sanjose
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Barcelona, Spain
Lancet Infect Dis 7:453-9. 2007..The HPV types most commonly detected are similar to those most commonly described in pre-neoplastic and cancer cases, although the relative contribution of HPV16 and HPV18 is substantially lower in cytologically normal women...
Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk populationM Paz Cañadas
Departament de Biologia Molecular, General Lab, Barcelona, Spain
J Clin Microbiol 42:1330-2. 2004..HPV was found in 43.6% of the women, and its prevalence at genital sites was similar. Prevalence was highest among women aged 20 years or younger but declined thereafter in specimens from all anogenital sites...
Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in SpainXavier Castellsague
Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL Institut Català d Oncologia ICO, Hospitalet de Llobregat, Barcelona, Spain
BMC Infect Dis 9:74. 2009..Studies on HPV infection in pregnant women and HPV transmission to the child have yielded inconsistent results...
Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in IndiaM Diaz
Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Programme, Catalan Institute of Oncology ICO, Av Gran Via, s n km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
Br J Cancer 99:230-8. 2008....
Human papillomavirus prevalence and type distribution in penile carcinomaC Miralles-Guri
Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program, Institut Catala d Oncologia, IDIBELL, L Hospitalet de Ll, Barcelona, Spain
J Clin Pathol 62:870-8. 2009..HPV prevalence in penile tumours is reported to be associated to a variety of morphological changes. Its determination will provide a better estimate for HPV related cancer burden and its preventable fraction...
Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findingsLaia Bruni
Unit of Infections and Cancer, Cancer Epidemiology Research Program, IDIBELL Institut Català d Oncologia, Barcelona, Spain
J Infect Dis 202:1789-99. 2010..Baseline information on human papillomavirus (HPV) prevalence and type distribution is highly desirable to evaluate the impact of prophylactic HPV vaccines in the near future...
HPV and cervical cancer: screening or vaccination?F X Bosch
Cancer Epidemiology and Registration Unit, IDIBELL, Institut Catala d Oncologia, L Hospitalet del Llobregat, Barcelona, Spain
Br J Cancer 98:15-21. 2008..Multidisciplinary efforts and novel protocols are being developed, and challenging situations are being faced to make cervical cancer, still the number two cancer in women worldwide, an eradicable condition...
[Incidence and survival of leukemias according to the different histologic subsets, in Tarragona, Spain, between 1980-1994]J R Gonzalez
Servicio de Prevencion y Control del Cancer Institut Catala d Oncologia L Hospitalet de Llobregat Barcelona
Med Clin (Barc) 116:174-8. 2001..To study the incidence and survival of leukemias according to the different histologic types in Tarragona, Spain...
Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-upJosepa Ribes
Epidemiology and Cancer Registration, Institut Catala d Oncologia, and Blod Bank, Hospital Universitari de Bellvitge, Hospitalet del Llobregat, Spain
Int J Cancer 119:687-94. 2006..These results support screening and adequate follow-up among HBsAg-positive subjects at high risk to develop liver disease, particularly when these risk cofactors are present...
Epidemiologic classification of human papillomavirus types associated with cervical cancerNubia Munoz
International Agency for Research on Cancer, Lyons, France
N Engl J Med 348:518-27. 2003..Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but the risk associated with the various HPV types has not been adequately assessed...
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and preventionXavier Castellsague
Institut d Investigacio Biomedica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d Oncologia L Hospitalet de Llobregat, Barcelona, Spain
J Natl Cancer Inst 98:303-15. 2006..The extent to which human papillomavirus (HPV) infection and cofactors may explain this differential trend is unclear...
Time trends in incidence and mortality for chronic liver disease and liver cancer in the interval 1980-1997 in Catalonia, SpainJosepa Ribes
Servei d Epidemiologia i Registre del Càncer Institut Català, d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
Eur J Gastroenterol Hepatol 16:865-72. 2004..The purpose of this study was to examine time trends of incidence and mortality rates of liver cirrhosis and liver cancer for the period 1980-1997 in Catalonia, Spain...
Against which human papillomavirus types shall we vaccinate and screen? The international perspectiveNubia Munoz
International Agency for Research on Cancer, Lyon, France
Int J Cancer 111:278-85. 2004..The impact of modifying the number of types in the screening cocktail tests would be small and probably irrelevant for screening programs...
Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult menXavier Castellsague
Cancer Epidemiology and Registration Unit, Institut d Investigacio Biomedica de Bellvitge, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
Am J Epidemiol 162:907-16. 2005..These findings suggest that male circumcision could reduce the risk of C. trachomatis infection in female sexual partners...
Environmental co-factors in HPV carcinogenesisXavier Castellsague
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Gran Vias n km 2, 7 08907 L Hospitalet de Llobregat, Barcelona, Spain
Virus Res 89:191-9. 2002....
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partnersXavier Castellsague
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Hospitalet de Llobregat, Barcelona, Spain
N Engl J Med 346:1105-12. 2002..It is uncertain whether male circumcision reduces the risks of penile human papillomavirus (HPV) infection in the man and of cervical cancer in his female partner...
Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control studyVictor Moreno
Epidemiology and Cancer Registry Service, Catalan Institute of Oncology, Hospital Duran i Reynals, L Hospitalet de Llobregat, Barcelona, Spain
Lancet 359:1085-92. 2002..We aimed to assess how use of oral contraceptives affected risk of cervical cancer in women who tested positive for HPV DNA...
Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based studySilvia de Sanjose
Institut Catala d Oncologia, Hospitalet de LL, Barcelona, Spain
Int J Cancer 106:588-93. 2003..The contribution of these genes to early-onset breast cancer is likely to be even higher given that certain UV cases might be disease-associated...
Cervical human papillomavirus infection in the female population in Barcelona, SpainSilvia de Sanjose
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Gran Via km 2 7 E 08907 L Hospitalet de Llobregat, Barcelona, Spain
Sex Transm Dis 30:788-93. 2003..Human papillomavirus (HPV) is a major cause of invasive cervical cancer. Identification of HPV determinants might allow for targeting of high-risk groups for cervical cancer...
The male role in cervical cancerXavier Castellsague
Institut Catala d Oncologia, Servel d Epidemiologia I Registre del Càncer, Gran Via s n, Km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
Salud Publica Mex 45:S345-53. 2003..More research is needed to better understand the natural history and epidemiology of HPV infections in men. This paper is available too at: http://www.insp.mx/salud/index.html...
Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in SpainSilvia de Sanjose
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
Int J Cancer 98:155-8. 2002..All PBMC samples were negative. These results suggest that in low-risk countries for KSHV, oral shedding and heterosexual contacts are potential pathways for KSHV transmission...
Role of hepatitis C virus infection in malignant lymphoma in SpainSilvia de Sanjose
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Barcelona, Spain
Int J Cancer 111:81-5. 2004..HCV infection is associated with an increased risk of a broad spectrum of lymphoid neoplasms among non severely immunocompromised subjects in Spain...
Epidemiology of primary liver cancerF X Bosch
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
Semin Liver Dis 19:271-85. 1999....
Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for preventionXavier Castellsague
IDIBELL, Institut Català d Oncologia ICO, L Hospitalet de Llobregat, Barcelona, Spain
Int J Cancer 122:1901-4. 2008..The introduction of an efficacious HPV 16/18 vaccine could potentially prevent the occurrence of 72% of cervical cancer cases and up to 81% of the cases if full cross-protection against HPVs 31 and 45 is assumed...
Patient with hepatocellular carcinoma related to prior acute arsenic intoxication and occult HBV: epidemiological, clinical and therapeutic results after 14 years of follow-upTeresa Casanovas-Taltavull
Department of Gastroenterology, Hospital Universitari de Bellvitge, IDIBELL, Feixa Llarga s n, 08907 L Hospitalet de Llobregat, Barcelona, Spain
World J Gastroenterol 12:1972-4. 2006..At his most recent visit in May 2005, the patient was asymptomatic, liver enzymes were normal and the tumor was in remission on ultrasound...
HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectivesXavier Castellsague
Cancer Epidemiology Research Program, Institut Catala d Oncologia, IDIBELL, CIBER ESP, Barcelona, Spain
Gynecol Oncol 115:S15-23. 2009..We consider oncogenic HPV infection and the risk of developing cervical cancer in women over 25 years of age and whether they would also benefit from vaccination against HPV...
HPV vaccines and cervical cancerF X Bosch
Cancer Epidemiology Research Program (CERP, IDIBELL, , L'Hospitalet del Llobregat, Barcelona, Spain
Ann Oncol 19:v48-51. 2008
Diet and K-ras mutations in colorectal cancerV Moreno
Catalan Institute of Oncology (ICO, Barcelona, Spain
IARC Sci Publ 156:501-2. 2002
Human papillomavirus vaccines and vaccine implementationSilvia de Sanjose
Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL and CIBER Epidemiología y Salud Pública CIBERESP, Barcelona, Spain
Womens Health (Lond Engl) 4:595-604. 2008..Finally, some major aspects that are likely to impact the introduction of these vaccines around the world are outlined, with particular emphasis on developing countries...
Hospital deaths of people aged 90 and over: end-of-life palliative care managementFrancesc Formiga
Geriatric Unit, Internal Medicine Service, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
Gerontology 54:148-52. 2008..In developed countries, hospital deaths at very advanced age are increasingly common. Few studies have addressed end-of-life care in very elderly patients with non-cancer chronic diseases...
Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromesXavier Bosch
Institut de Malalties Cardiovasculars, Hospital Clinic, , Barcelona, Spain
Am Heart J 150:215-20. 2005..CONCLUSIONS: The TIMI risk score predicts inhospital mortality in a broad population of patients with ACS. The further consideration of EF adds significant prognostic information...
Preface. The field of cervical cancer preventionF Xavier Bosch
Epidemiology and Cancer Registry Unit, IDIBELL, , Avenida Gran Via s/n, L'Hospitalet de Llobregat, Barcelona, Spain
Vaccine 24:S3/v-vi. 2006
New insights in the management of cardiogenic shock complicating myocardial infarction: role of urgent heart transplantationDabit Arzamendi
Cardiology Unit, Cardio Thorax Institute Hospital Clinic de Barcelona, Barcelona, Spain
J Heart Lung Transplant 27:984-9. 2008..The primary end-point of the study was mortality at the 1-year follow-up...
A practical approach with outcome for the prognostic assessment of non-ST-segment elevation chest pain and normal troponinJuan Sanchis
Servei de Cardiologia, Hospital Clinic Universitari, Universitat de Valencia, Barcelona, Spain
Am J Cardiol 99:797-801. 2007....
WAERS: an application for Web-assisted estimation of relative survivalRamon Clèries
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat Spain, Barcelona, Spain
Med Inform Internet Med 32:169-75. 2007..This application can be also useful for cohort mortality studies and for registries of several diseases...
Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric studyPadmaja Patnaik
Department of Epidemiology, CB 7435, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7435, USA
Sex Transm Dis 34:1019-24. 2007..To determine type-specific seroprevalence of herpes simplex viruses (HSV-1 and HSV-2) and HSV-2 risk factors...
Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in SpainLuis M Puig-Tintore
Gynecologic Oncology, Hospital Clinic, University of Barcelona, Catalonia, Spain
J Low Genit Tract Dis 12:82-9. 2008..To quantify the coverage and monitor the factors associated with opportunistic cervical cytological screening in Spain...
Is viral status needed before vaccination?Thomas C Wright
Department of Pathology, Columbia University, Room 16 404, P and S Building, 630 West 168th Street, New York, NY, United States
Vaccine 26:A12-5. 2008..The increase in cost and the other barriers afforded by a prior to vaccination test requirement would result in a lower coverage, the key indicator of a successful vaccination program...
Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control studyNubia Munoz
Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372, Cedex 08, Lyon, France
Lancet 359:1093-101. 2002..To assess the role of reproductive factors in the progression from HPV infection to cancer, we did a pooled analysis including only HPV-positive women...
Aflatoxin, hepatitis and worldwide liver cancer risksSara H Henry
U.S. Food and Drug Administration, Washington, DC 20204, USA
Adv Exp Med Biol 504:229-33. 2002....
Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the PhilippinesJennifer S Smith
International Agency for Research on Cancer, F 69372 Lyon Cedex 08, France
J Infect Dis 185:324-31. 2002..C. trachomatis infection was found to be a possible cofactor of HPV in the etiology of squamous cervical cancer, and its effect may be mediated by chronic inflammation...
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trialJorma Paavonen
University of Helsinki, Department of Obstetrics and Gynaecology, Helsinki, Finland
Lancet 369:2161-70. 2007....
Cervical cancer control, priorities and new directionsJoseph Monsonego
EUROGIN, Paris, France
Int J Cancer 108:329-33. 2004..We report the conclusions of the Experts' Meeting at the EUROGIN 2003 conference...
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter studyRolando Herrero
International Agency for Research on Cancer, Lyon, France. rherrero@ amnet.co.cr
J Natl Cancer Inst 95:1772-83. 2003..The most common HPV type in genital cancers (HPV16) was also the most common in these tumors. The mechanism of transmission of HPV to the oral cavity warrants further investigation...
Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control studyMartyn Plummer
Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372 Lyon, France
Cancer Causes Control 14:805-14. 2003..This analysis is part of a series of analyses of cofactors of HPV in the aetiology of cervical cancer...
Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancerJennifer S Smith
Unit of Field and Intervention Studies, International Agency for Research on Cancer IARC, Lyon, France
J Natl Cancer Inst 94:1604-13. 2002..We performed a pooled analysis of seven case-control studies to examine the effect of one possible HPV cofactor, herpes simplex virus-2 (HSV-2) infection, in the etiology of invasive cervical cancer...
Variations in the age-specific curves of human papillomavirus prevalence in women worldwideSilvia Franceschi
International Agency for Research on Cancer, Lyon, France
Int J Cancer 119:2677-84. 2006..These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences...
Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control studyJennifer S Smith
International Agency for Research on Cancer, Lyon, France
Int J Cancer 111:431-9. 2004..0; 95% CI = 0.53-1.9) in HPV DNA-positive women. An association of C. trachomatis with squamous cell ICC was found among all cases and control women with or without adjustment for HPV...
Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional studySilvia Franceschi
International Agency for Research on Cancer, Lyon, France
Sex Transm Dis 34:563-9. 2007..Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas...
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccineSue J Goldie
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115 5924, USA
J Natl Cancer Inst 96:604-15. 2004..We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 vaccine in a population with an organized cervical cancer screening program...
Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasionYali Zhai
Department of Pathology, University of Michigan Medical School and Biostatistics Department, University of Michigan School of Public Health, Ann Arbor, Michigan 48109-2216, USA
Cancer Res 65:6543-50. 2005..Further studies of gene expression in preinvasive and invasive cervical cancers should assist with identification of additional critical factors mediating cervical cancer progression...
Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18Jose C Prado
Ludwig Institute for Cancer Research, Sao Paulo, Brazil
Virology 340:95-104. 2005....
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph ConsortiumNathaniel Rothman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
Lancet Oncol 7:27-38. 2006..We aimed to test this hypothesis using previously unpublished data from eight European, Canadian, and US case-control studies of the International Lymphoma Epidemiology Consortium (InterLymph)...
Can screening for cervical cancer be improved, especially in developing countries?Anthony B Miller
Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany
Int J Cancer 107:337-40. 2003
Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancerEduardo L Franco
Division of Cancer Epidemiology, Departments of Oncology and Epidemiology and Biostatistics, McGill University, 546 Pine Avenue West, Montreal, Quebec, Canada
Vaccine 24:S3/242-9. 2006..The field of HPV and cervical cancer prevention has never been so multi-disciplinary. A new era has begun and the challenges are many...
Organotypic co-cultures allow for immortalized human gingival keratinocytes to reconstitute a gingival epithelial phenotype in vitroMariana Roesch-Ely
Ear-Nose-and-Throat Hospital, University of Heidelberg, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany
Differentiation 74:622-37. 2006..We are not aware of any other OCC system comprising of IHGK, which allows for site-specific expression of gingival epithelial markers. This substantiates reconstitution of a gingival epithelial phenotype in vitro...
Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international expertsThomas C Wright
Department of Pathology, Columbia University, 630 W 168th Street, NY 10032, USA
Vaccine 24:S3/251-61. 2006..In this summary, we summarize the opinions of this expert group on how these advances can be introduced to provide the maximum benefit to women and to reduce the global burden of cervical cancer...
Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirionsMaxime J J Fleury
INSERM U618, Tours, France
Clin Vaccine Immunol 15:172-5. 2008..Neutralizing antibodies were detected in 78% of subjects with a positive enzyme-linked immunosorbent assay...
